BACKGROUND: Paroxetine is an antidepressant that is widely used. However, Paroxetine possesses anticholinergic properties which may contribute to cognitive decline in older adults. Surprisingly, the mechanisms of the cognitive decline of anticholinergic drugs in older adults remains elusive. A hypothesis is that a loss of cholinergic signaling is pro-inflammatory in the brain. We designed experiments to determine if Paroxetine is pro-inflammatory in Normal Human Brain Microvascular Endothelial Cells (NHBMECs). METHOD: NHBMECs were grown at 5% CO2, 37C and 95% relative humidity until 90% confluent. NHBMECs were treated with the RNA free water as control, Paroxetine as 1.67x 10 4 mM/mol, IL1B 2ng/ml for 24 hours. RNA was isolated, converted i...
Introduction: Recent studies have shown that astrocytes play major roles in normal and disease condi...
Xenobiotics use and impact on human being is one of the major public health concerns. Despite their ...
A selective serotonin reuptake inhibitor, fluoxetine, has recently attracted a significant interest ...
Studies reveal that 10-27% of older adults chronically use anticholinergic medications. Increased cu...
AbstractThe extracellular L-glutamate (L-Glu) concentration is elevated in neuroinflammation, thereb...
Selective serotonin reuptake inhibitors (SSRIs) are frequently used to treat depression during pregn...
We have conducted a phenotypic screening in endothelial cells exposed to elevated extracellular gluc...
Neuronal upregulation of the brain-derived neurotrophic factor (BDNF) gene appears to be a crucial f...
Program no. 552.3Background: Clinical experience and previous research showed that cognitive deficie...
Purpose: Major depressive disorder is often associated with elevated glucocorticoid levels, which in...
Background: Left ventricular (LV) remodeling consists in maladaptive changes in cardiac geometry and...
The aim of this study was to identify molecular pathways related to antidepressant response. We admi...
Vilazodone is a novel antidepressant agent that combines selective serotonin (5-HT) reuptake inhibit...
Chemotherapy has been highly successful in treating many forms of cancer; however there are increasi...
Vilazodone is a novel antidepressant agent that combines selective serotonin (5-HT) reuptake inhibit...
Introduction: Recent studies have shown that astrocytes play major roles in normal and disease condi...
Xenobiotics use and impact on human being is one of the major public health concerns. Despite their ...
A selective serotonin reuptake inhibitor, fluoxetine, has recently attracted a significant interest ...
Studies reveal that 10-27% of older adults chronically use anticholinergic medications. Increased cu...
AbstractThe extracellular L-glutamate (L-Glu) concentration is elevated in neuroinflammation, thereb...
Selective serotonin reuptake inhibitors (SSRIs) are frequently used to treat depression during pregn...
We have conducted a phenotypic screening in endothelial cells exposed to elevated extracellular gluc...
Neuronal upregulation of the brain-derived neurotrophic factor (BDNF) gene appears to be a crucial f...
Program no. 552.3Background: Clinical experience and previous research showed that cognitive deficie...
Purpose: Major depressive disorder is often associated with elevated glucocorticoid levels, which in...
Background: Left ventricular (LV) remodeling consists in maladaptive changes in cardiac geometry and...
The aim of this study was to identify molecular pathways related to antidepressant response. We admi...
Vilazodone is a novel antidepressant agent that combines selective serotonin (5-HT) reuptake inhibit...
Chemotherapy has been highly successful in treating many forms of cancer; however there are increasi...
Vilazodone is a novel antidepressant agent that combines selective serotonin (5-HT) reuptake inhibit...
Introduction: Recent studies have shown that astrocytes play major roles in normal and disease condi...
Xenobiotics use and impact on human being is one of the major public health concerns. Despite their ...
A selective serotonin reuptake inhibitor, fluoxetine, has recently attracted a significant interest ...